Connecting the Dots: Inflammatory Burden and Outcomes in Heart Failure
Open Access
- 3 October 2023
- journal article
- editorial
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (19) , e031786
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart FailureCirculation, 2019
- IL-1 Blockade in Patients With Heart Failure With Preserved Ejection FractionCirculation: Heart Failure, 2018
- The NLRP3 inflammasome in acute myocardial infarctionNature Reviews Cardiology, 2017
- Interleukin-1 Blockade in Recently Decompensated Systolic Heart FailureCirculation: Heart Failure, 2017
- Cumulative Exposure to High‐Sensitivity C‐Reactive Protein Predicts the Risk of Cardiovascular DiseaseJournal of the American Heart Association, 2017
- Effects of Interleukin-1 Blockade With Anakinra on Aerobic Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction (from the D-HART Pilot Study)The American Journal of Cardiology, 2014
- Interleukin-1β induces a reversible cardiomyopathy in the mouseInflammation Research, 2013
- Enhanced Interleukin-1 Activity Contributes to Exercise Intolerance in Patients with Systolic Heart FailurePLOS ONE, 2012
- Inflammation and long-term mortality in acute congestive heart failureAmerican Heart Journal, 2006
- C-Reactive Protein in Heart FailureCirculation, 2005